TRACON Pharmaceuticals Competitors and Similar CompaniesClear all
TRACON Pharmaceuticals's competitors and similar companies include Infinity Pharmaceuticals, Sunesis Pharmaceuticals, Peloton Therapeutics and Lemonex.
 TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. |  Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. |  Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. |  Peloton Therapeutics Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments. |  Lemonex Lemonex (레모넥스) is a company that focuses on the development and commercialization of cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. | |
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 1987 | Founding Date 2011 | Founding Date 2013 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Cambridge, US HQ | Locations South San Francisco, US HQ | Locations Dallas, US HQ San Francisco, US | Locations KR HQ |
Employees | Employees 268% increase | Employees 25 | Employees 42 | Employees 554% increase | Employees 7 |
Valuation ($) | Valuation ($) 279.4 k | Valuation ($) 726.1 k | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($3.6m) (FY, 2023) | Net income ($44.4m) (FY, 2022) | Net income ($114.8m) (FY, 2021) | Net income ($36.1m) (FY, 2018) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 41m | Total funding raised $ 106.6m | Total funding raised $ 171.7m | Total funding raised $ 92.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
25
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
View companySunesis Pharmaceuticals
HQ
South San Francisco, US
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View companyPeloton Therapeutics
HQ
Dallas, US
Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments.
View companyLemonex
HQ
KR
Employees
7
Lemonex (레모넥스) is a company that focuses on the development and commercialization of cancer immunotherapeutics, antibody therapeutics, and gene therapeutics.
View company